Rafael Esteban researcher
Esteban, Rafael, 1939-
Esteban, Rafael (Esteban Mur)
Esteban Mur, Rafael
Esteban, Rafael
VIAF ID: 36236781 (Personal)
Permalink: http://viaf.org/viaf/36236781
Preferred Forms
-
100 1 _ ‡a Esteban Mur, Rafael
-
-
-
100 1 _ ‡a Esteban, Rafael ‡d 1939-
-
-
100 1 0 ‡a Esteban, Rafael, ‡d 1939-
-
-
100 0 _ ‡a Rafael Esteban ‡c researcher
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
[Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection |
![]() |
Dame Sheila Sherlock : discurs llegit a la cerimònia d'investidura celebrada a la sala d'actes de l'Hospital de la Vall d'Hebron de Barcelona el dia 31 de maig de l'any 1991 |
![]() |
Estudio de la especificidad "E" del HBsAg : interés clínico y epidemiológico |
![]() ![]() |
From complicity to encounter, 1998: |
![]() ![]() ![]() |
Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate |
![]() |
Hepatocellular carcinoma and hepatitis B virus markers in Europe |
![]() |
Implementing universal vaccination programmes: Spain |
![]() |
Improved attachment of natural HCV isolate to Daudi cells upon elimination of immune complexes and close pH control |
![]() |
Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites |
![]() |
Inhibition of neuronal apoptosis and axonal regression ameliorates sympathetic atrophy and hemodynamic alterations in portal hypertensive rats |
![]() |
Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis |
![]() |
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. |
![]() |
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis |
![]() |
Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine? |
![]() |
Letters to the Editor |
![]() |
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin. |
![]() |
Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding. |
![]() |
Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B. |
![]() |
Management of direct-acting antiviral agent failures |
![]() |
Management of hepatitis C virus genotype 4: recommendations of an international expert panel. |
![]() |
Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina |
![]() |
Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. |
![]() |
Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient |
![]() |
New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors |
![]() |
New therapeutic perspectives in HBV: when to stop NAs. |
![]() |
Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients |
![]() |
Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. |
![]() |
Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. |
![]() |
Patient experience in HCV therapy: what really matters. |
![]() |
[Position paper of the Catalan Society of Gastroenterology: treatment of Genotype 1 Chronic Hepatitis C Virus with Triple Therapy]. |
![]() |
Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. |
![]() |
Preparing the patient for success: treat or wait? |
![]() |
Quality of life in cirrhosis is related to potentially treatable factors. |
![]() |
Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing |
![]() |
Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. |
![]() |
Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. |
![]() |
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study. |
![]() |
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response |
![]() |
Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals |
![]() |
Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues |
![]() |
The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats |
![]() |
Reply to: "The importance of prognostic factors in cirrhosis". |
![]() |
Retos actuales en el manejo de la hepatitis crónica B (HCB) |
![]() |
Ribavirin therapy in chronic delta hepatitis. |
![]() |
The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. |
![]() |
[Risk of transmission of HIV or hepatitis B or C viruses from an infected physician. Preventive measures] |
![]() |
Role of screening in prevention and treatment. |
![]() |
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C |
![]() |
Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials |
![]() |
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype |
![]() |
Sexual transmission of hepatitis C virus from a patient with chronic disease to his sex partner after removal of an intrauterine device |
![]() |
Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant |
![]() |
Sofosbuvir and ribavirin in HCV genotypes 2 and 3. |
![]() |
Sporadic cases of acute autochthonous hepatitis E in Spain |
![]() |
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. |
![]() |
Study of hepatitis B virus replication and infection by other hepatitis viruses in patients with chronic hepatitis B virus infection |
![]() |
Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab |
![]() |
Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection. |
![]() |
Therapy for hepatitis C genotype 3: moving forward. |
![]() |
Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp? |
![]() |
Thrombocytopenia associated with chronic liver disease |
![]() |
Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. |
![]() |
Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome |
![]() |
Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy |
![]() |
Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA. |
![]() |
Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment |
![]() |
Valor predictivo del fenotipo molecular sobre la progresión de las lesiones renales en biopsias de seguimiento en trasplante renal |
![]() |
The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection |
![]() |
Viral hepatitis |
![]() ![]() ![]() |